TY - JOUR
T1 - Screening for Syphilis Infection in Nonpregnant Adults and Adolescents
T2 - US Preventive Services Task Force Recommendation Statement
AU - US Preventive Services Task Force (USPSTF)
AU - Bibbins-Domingo, Kirsten
AU - Grossman, David C.
AU - Curry, Susan J.
AU - Davidson, Karina W.
AU - Epling, John W.
AU - García, Francisco A.R.
AU - Gillman, Matthew W.
AU - Harper, Diane M.
AU - Kemper, Alex R.
AU - Krist, Alex H.
AU - Kurth, Ann E.
AU - Landefeld, C. Seth
AU - Mangione, Carol M.
AU - Phillips, William R.
AU - Phipps, Maureen G.
AU - Pignone, Michael P.
N1 - Funding Information:
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
PY - 2016/6/7
Y1 - 2016/6/7
N2 - IMPORTANCE In 2014, 19 999 cases of syphilis were reported in the United States. Left untreated, syphilis can progress to late-stage disease in about 15%of persons who are infected. Late-stage syphilis can lead to development of inflammatory lesions throughout the body, which can lead to cardiovascular or organ dysfunction. Syphilis infection also increases the risk for acquiring or transmitting HIV infection. OBJECTIVE To update the 2004US Preventive Services Task Force (USPSTF) recommendation on screening for syphilis infection in nonpregnant adults. Screening for syphilis in pregnant womenwas updated in a separate recommendation statement in 2009 (A recommendation). EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for syphilis infection in asymptomatic, nonpregnant adults and adolescents, including patients coinfected with other sexually transmitted infections (such as HIV). FINDINGS The USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. Accurate screening tests are available to identify syphilis infection in populations at increased risk. Effective treatment with antibiotics can prevent progression to late-stage disease, with small associated harms, providing an overall substantial health benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection. (A recommendation).
AB - IMPORTANCE In 2014, 19 999 cases of syphilis were reported in the United States. Left untreated, syphilis can progress to late-stage disease in about 15%of persons who are infected. Late-stage syphilis can lead to development of inflammatory lesions throughout the body, which can lead to cardiovascular or organ dysfunction. Syphilis infection also increases the risk for acquiring or transmitting HIV infection. OBJECTIVE To update the 2004US Preventive Services Task Force (USPSTF) recommendation on screening for syphilis infection in nonpregnant adults. Screening for syphilis in pregnant womenwas updated in a separate recommendation statement in 2009 (A recommendation). EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for syphilis infection in asymptomatic, nonpregnant adults and adolescents, including patients coinfected with other sexually transmitted infections (such as HIV). FINDINGS The USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. Accurate screening tests are available to identify syphilis infection in populations at increased risk. Effective treatment with antibiotics can prevent progression to late-stage disease, with small associated harms, providing an overall substantial health benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection. (A recommendation).
UR - http://www.scopus.com/inward/record.url?scp=84973358416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84973358416&partnerID=8YFLogxK
U2 - 10.1001/jama.2016.5824
DO - 10.1001/jama.2016.5824
M3 - Review article
C2 - 27272583
AN - SCOPUS:84973358416
SN - 0098-7484
VL - 315
SP - 2321
EP - 2327
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 21
ER -